ストックスクリーナーアプリを入手
19.14
3.53%
-0.70
前日終値:
$19.84
開ける：
$19.31
24時間の取引高:
23.37M
Relative Volume:
0.72
時価総額：
$4.36B
収益：
$2.35B
当期純損益:
$128.37M
株価収益率:
36.66
EPS:
0.5221
ネットキャッシュフロー:
$57.42M
1週間 パフォーマンス:
-8.25%
1か月 パフォーマンス:
+16.14%
6か月 パフォーマンス:
-66.93%
1年 パフォーマンス:
-38.69%
1日の値動き範囲:
$18.75
$19.50
1週間の範囲:
$18.62
$21.62
52週間の値動き範囲:
$13.74
$70.43
Hims Hers Health Inc Stock (HIMS) Company Profile
Compare HIMS vs TAK, ZTS, HLN, TEVA, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
19.14 | 4.36B | 2.35B | 128.37M | 57.42M | 0.5221 |
TAK
Takeda Pharmaceutical Co Adr
|
18.74 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
117.94 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.93 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.08 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
564.81 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-10 | アップグレード | BofA Securities | Underperform → Neutral |
| 2026-03-10 | アップグレード | Citigroup | Sell → Neutral |
| 2026-03-09 | アップグレード | Needham | Hold → Buy |
| 2026-02-24 | ダウングレード | BTIG Research | Buy → Neutral |
| 2026-01-12 | 開始されました | Evercore ISI | In-line |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-10-21 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | ダウングレード | Needham | Buy → Hold |
| 2025-06-04 | 繰り返されました | Needham | Buy |
| 2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-01-07 | 開始されました | BTIG Research | Buy |
| 2024-12-17 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-08-22 | 開始されました | Needham | Buy |
| 2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-10 | 開始されました | Canaccord Genuity | Buy |
| 2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | Imperial Capital | In-line |
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
Hims Data Breach Tests Trust As Valuation Gap Attracts Investors - Yahoo Finance
Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data Breach - GlobeNewswire Inc.
Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data Breach - PR Newswire
Hims & Hers Health Faces Investor Lawsuit Over Alleged Misconduct - National Today
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc.HIMS - Business Wire
Hims & Hers hack: Telehealth company reports customer support system breach - americanbazaaronline.com
Hims & Hers Health, Inc. (HIMS) stock price, news, quote and history - Yahoo Finance Singapore
Healthcare Stocks To Watch TodayApril 3rd - MarketBeat
Hims & Hers warns of data breach after Zendesk support ticket breach - BleepingComputer
Hims & Hers Health, Inc. (HIMS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Hims and Hers reveal cyberattack — customer support system hacked and personal info stolen, here's what we know - TechRadar
Hims & Hers' Valuations Back To EarthRobust Monetization Trends Deserve Reiterated Buy - Seeking Alpha
Hims & Hers Health stock price forecast: sideways consolidation likely as HIMS falls 3.53% - Traders Union
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock - Yahoo Finance
HIMS stock gains as FDA reportedly moves toward lifting restrictions on peptides - MSN
AI for investors - MLQ.ai
Security Breach and Trade Policy Fears Weigh on Hims & Hers Stock - AD HOC NEWS
Should You Buy Hims Stock Today? - theglobeandmail.com
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know - Yahoo Finance
Hims & Hers flags suspicious activity linked to third‑party customer service vendor - TradingView
Hims & Hers Data Breach Exposes Customer Service Records - Claim Depot
Building Better Health: AI as the Operating System for Care - Hims & Hers Newsroom
Broad selling pressure keeps Hims & Hers stock restrained after telehealth expansion news - Traders Union
Barclays raises PT on Hims & Hers Health (HIMS) stock - MSN
Hims & Hers Health, Inc. (HIMS) Outperforms Broader Market: What You Need to Know - MSN
US FDA clarifies policies on compounding of GLP-1 medicines - Reuters
Hims & Hers Health Inc (HIMS) Stock Price, Trades & News - GuruFocus
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
-3.88% for Hims & Hers Health stock as oscillators give mixed signals near session low - Traders Union
Hims & Hers Stock Is Down 63% Over the Past 6 Months. Here’s Why the Valuation Still Looks Compelling - TIKR.com
Novo Partnership Fuels Long-Term Optimism for Hims & Hers Health, Inc. (HIMS) - Insider Monkey
Hims & Hers expands personalized digital healthcare platform - MSN
Hims & Hers Broadens Tailored Online Health Services Platform - Bitget
Hims & Hers Health Inc (HIMS) Stock Price Up 6.42% on Mar 31 - GuruFocus
Hims & Hers Expands Personalized Digital Healthcare Platform - tradingview.com
HIMS Gains as FDA Revisits Rules on Compounding Pharmacies - GuruFocus
HIMS Stock Gains As FDA Reportedly Moves Toward Lifting Restrictions On Peptides - Stocktwits
Did Hims & Hers' Novo Nordisk GLP-1 Partnership Just Shift Hims & Hers Health's (HIMS) Investment Narrative? - Sahm
Hims Novo Nordisk GLP-1 Launch Ties Growth Story To Valuation Gap - simplywall.st
Hims & Hers Health, Inc. (HIMS) registers a bigger fall than the market: Important facts to note - MSN
HIMS Sees Moderate Bearish Sentiment Among Option Traders - GuruFocus
Hims & Hers Health, Inc. (HIMS) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Hims & Hers Health Options Spot-On: On March 30th, 88,151 Contracts Were Traded, With 1.15 Million Open Interest - Moomoo
Assessing Hims & Hers Health (HIMS) Valuation After A Sharp Pullback And Long Term Shareholder Gains - Sahm
HIMS stock in spotlight after Hims & Hers adds Novo’s GLP-1 treatments to its platform - MSN
Why (HIMS) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Hims & Hers Health, Inc. (HIMS) Experiences a Sharper Decline Compared to the Overall Market: Key Points to Consider - bitget.com
Hims & Hers Health stock price forecast: persistent bearish setup as HIMS extends decline toward $18 - Traders Union
SG Americas Securities LLC Boosts Stock Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health Options Spot-On: On March 27th, 145.81K Contracts Were Traded, With 1.12 Million Open Interest - Moomoo
Hims & Hers Stock Decline Amid Legal Battles and Strategic Repositioning - StocksToTrade
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
1.11%
大文字化:
|
ボリューム (24 時間):